Short-term activation of splenic NK cells with IL-12 and IL-18 (IL-12/18) gives rise to a population of cells with durable enhanced production of IFN-γ in response to restimulation with cytokines, thereby activating receptor ligands or tumor targets5. The gene discussed is IFNG; the disease is neoplasm.